Chondroid chordoma

Summary

Chondroid chordoma (MONDO:0006145) is a disease. A subtype of chordoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	chondroid chordoma
Mondo ID	MONDO:0006145
EFO	EFO:1000174
DOID	DOID:4152
NCIT	C6902
UMLS	C1266173
MedGen	224768
GARD	0024310
Is cancer (heuristic)	no

Also known as: chondroid chordoma · chondroid chordoma (morphologic abnormality)

Disease family

This is a subtype of chordoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › embryonal neoplasm › notochordal tumor › chordoma › chondroid chordoma

Related subtypes (3): skull base chordoma, spinal chordoma, poorly differentiated chordoma

Subtypes (1): clivus chondroid chordoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.